Stocktoria
Sanofi SAN.PA
Sanofi statistics & valuation
Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value (€92.62); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
Sanofi trades at about 11.9× earnings — below its 10-year norm (10-year range 12.4×–22.7×, median 21.7×).
Shaded band = 10-year range (12.4×–22.7×); dot = today's 11.9×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | 72.1% | 70.2% | 69.7% | 70.7% |
| Operating margin | 20.5% | 20.1% | 20.9% | 26.9% |
| Net margin | 16.7% | 12.6% | 13.0% | 20.6% |
| FCF margin | 15.4% | 13.3% | 17.7% | 20.8% |
| Return on assets | 6.2% | 4.2% | 4.3% | 6.6% |
| Return on equity | 10.9% | 7.2% | 7.3% | 11.2% |
| Debt / equity | 0.20× | 0.15× | 0.19× | 0.20× |
| Current ratio | 1.09 | 1.46 | 1.27 | 1.42 |
Computed from company filings · FR · as of 2025-12-31. Figures in EUR. Facts plus Stocktoria's own computed scores — not investment advice.